Osaic Holdings’s Amplify Weight Loss Drug & Treatment ETF THNR Stock Holding History

Osaic Holdings’s Portfolio THNR Stock Details THNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.14K	Buy	+356	New	+$8.76K	﹤0.01%	6655

Other funds holding THNR

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GFA

Godfrey Financial Associates Glenmont, New York $131M AUM

Osaic Holdings's THNR Position: Q2 2026 in Review

Osaic Holdings opened a new position in Amplify Weight Loss Drug & Treatment ETF (THNR) in Q2 2026: 356 shares worth $9.14K. The stake represents ﹤0.01% of the portfolio and ranks #6655 among its holdings.

4 funds tracked by Wall St. Rank hold THNR as of Q2 2026.

Osaic Holdings held 356 shares of Amplify Weight Loss Drug & Treatment ETF worth $9.14K as of Q2 2026.
Amplify Weight Loss Drug & Treatment ETF was a new Osaic Holdings position in Q2 2026.
Amplify Weight Loss Drug & Treatment ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6655 holding.
4 funds tracked by Wall St. Rank held Amplify Weight Loss Drug & Treatment ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.